Journal Article

DKFZ-2023-01138

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.

Uzun, S. ; Zinner, C. ; Beenen, A. C. ; Alborelli, I. ; Bartoszek, E. M. ; Yeung, J. ; Calgua, B. ; Reinscheid, M. ; Bonsert, P. ; Stalder, A. K. ; Haslbauer, J. ; Vosbeck, J. ; Mazzucchelli, L. ; Hoffmann, T. ; Terracciano, L. M. ; Hutter, G. ; Manz, M. ; Panne, I. ; Böttler, T. ; Hofmann, M. ; Bengsch, B.DKFZ* ; Heim, M. H. ; Bernsmeier, C. ; Jiang, S. ; Tzankov, A. ; Beretta-Piccoli, B. T. ; Matter, M. S.

2023
Wiley-Blackwell [Erscheinungsort nicht ermittelbar]

This record in other databases:  

Please use a persistent id in citations: doi:10.1016/j.jhep.2023.05.020

Abstract: Liver injury after COVID-19 vaccination is very rare and shows clinical and histomorphological similarities with autoimmune hepatitis (AIH). Little is known about the pathophysiology of COVID-19 vaccine-induced liver injury (VILI) and its relationship to AIH. Therefore, we compared VILI with AIH.Formalin-fixed and paraffin-embedded liver biopsy samples from patients with VILI (n=6) and from patients with an initial diagnosis of AIH (n=9) were included. Both cohorts were compared by histomorphological evaluation, whole-transcriptome and spatial transcriptome sequencing, multiplex immunofluorescence and immune repertoire sequencing.Histomorphology was similar in both cohorts but showed more pronounced centrilobular necrosis in VILI. Gene expression profiling showed that mitochondrial metabolism and oxidative stress-related pathways were more and interferon response pathways less enriched in VILI. Multiplex analysis revealed that inflammation in VILI was dominated by CD8+ effector T cells, similar to drug-induced autoimmune like hepatitis (DI-AILH). In contrast, AIH showed a dominance of CD4+ effector T cells and CD79a+ B and plasma cells. T-cell receptor (TCR) and B-cell receptor (BCR) sequencing showed that T- and B-cell clones were more dominant in VILI than in AIH. In addition, many T-cell clones detected in the liver were also found in the blood. Interestingly, analysis of TCR beta chain and Ig heavy chain variable-joining gene usage further showed that TRBV6-1, TRBV5-1, TRBV7-6 and IgHV1-24 genes are used differently in VILI than in AIH.Our analyses support that SARS-CoV-2 vaccination-induced liver injury is related to AIH but also shows distinct differences from AIH in histomorphology, pathway activation, cellular immune infiltrates, and TCR usage. VILI may be a separate entity, which is distinct from AIH and more closely related to DI-AILH.Little is known about the pathophysiology of COVID-19 vaccine-induced liver injury. Our analysis shows that COVID-19 vaccine-induced liver injury shares some similarities with autoimmune hepatitis, but also has distinct differences such as increased activation of metabolic pathways, a more prominent CD8+ T cell infiltrate, and an oligoclonal T and B cell response. Our findings suggest that vaccine-induced liver injury is a distinct disease entity. Therefore, there is a good chance that many patients with COVID-19 vaccine-induced liver injury will recover completely and do not develop long-term autoimmune hepatitis.

Keyword(s): Autoimmune hepatitis ; COVID-19 ; Drug Induced Liver Injury ; SARS-CoV-2 ; vaccination

Note: 2023 Sep;79(3):666-676

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Freiburg (FR01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2023

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 25 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---